Utilization of Anticoagulants in Atrial Fibrillation: Influences of Clinical Risk Scores in Real-World Practice

被引：0
|
作者：
Lauffenburger, Julie C. [1 ]
Farley, Joel F. [1 ]
Rhoney, Denise H. [1 ]
Gehi, Anil K. [2 ]
Brookhart, M. Alan [3 ]
Fang, Gang [1 ]
机构：
[1] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
336
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [1] Real-world adherence to oral anticoagulants in atrial fibrillation
    Simonyi Gabor
    Paksy Andras
    Varnai Reka
    Medvegy Mihaly
    [J]. ORVOSI HETILAP, 2020, 161 (20) : 839 - 845
  • [2] Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World Setting
    Melillo, Enrico
    Rago, Anna
    Proietti, Riccardo
    Attena, Emilio
    Carrella, Maddalena
    Golino, Paolo
    D'Onofrio, Antonio
    Nigro, Gerardo
    Russo, Vincenzo
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (06) : 564 - 569
  • [3] Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
    Manzoor, Beenish S.
    Lee, Todd A.
    Sharp, Lisa K.
    Walton, Surrey M.
    Galanter, William L.
    Nutescu, Edith A.
    [J]. PHARMACOTHERAPY, 2017, 37 (10): : 1221 - 1230
  • [4] Clinical Performance of Nonvitamin K Antagonist Oral Anticoagulants in Real-World Obese Patients with Atrial Fibrillation
    Russo, Vincenzo
    Bottino, Roberta
    Rago, Anna
    Papa, Andrea Antonio
    Liccardo, Biagio
    D'Onofrio, Antonio
    Golino, Paolo
    Nigro, Gerardo
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020, 46 (08): : 970 - 976
  • [5] Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective
    Altman R.
    Vidal H.O.
    [J]. Thrombosis Journal, 9 (1)
  • [6] Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
    Ding, W. Y.
    Rivera-Caravaca, J. M.
    Marin, F.
    Roldan, V.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 470 - 470
  • [7] REAL-WORLD PRACTICE PATTERNS OF DOFETILIDE AND SOTALOL UTILIZATION FOR ATRIAL FIBRILLATION: A MULTI-NATIONAL SURVEY
    Reddy, Madhu
    Pillarisetti, Jayasree
    Iskandar, Sandia
    Atoui, Moustapha
    Lavu, Madhav
    Atkins, Donita
    Bommana, Sudharani
    Pimentel, Rhea
    Berenbom, Loren
    Dendi, Raghuveer
    Emert, Martin
    Lakkireddy, Dhanunjaya
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 736 - 736
  • [8] New Direct Oral Anticoagulants for Treatment of Patients with Atrial Fibrillation in Real-World Setting
    Kobalava, Zhanna D.
    Villevalde, Svetlana V.
    Shavarov, Andrey A.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2018, 14 (02) : 298 - 305
  • [9] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization
    Schaumberg, Debra
    Larholt, Kay
    Apgar, Elizabeth
    Pashos, Chris L.
    Hirsch, Gigi
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 472 - 475
  • [10] Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization
    Debra Schaumberg
    Kay Larholt
    Elizabeth Apgar
    Chris L. Pashos
    Gigi Hirsch
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 472 - 475
12345